Correlation Between X4 Pharmaceuticals and Xilio Development

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Xilio Development, you can compare the effects of market volatilities on X4 Pharmaceuticals and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Xilio Development.

Diversification Opportunities for X4 Pharmaceuticals and Xilio Development

-0.37
  Correlation Coefficient

Very good diversification

The 3 months correlation between XFOR and Xilio is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Xilio Development go up and down completely randomly.

Pair Corralation between X4 Pharmaceuticals and Xilio Development

Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.79 times more return on investment than Xilio Development. However, X4 Pharmaceuticals is 1.79 times more volatile than Xilio Development. It trades about 0.1 of its potential returns per unit of risk. Xilio Development is currently generating about -0.06 per unit of risk. If you would invest  306.00  in X4 Pharmaceuticals on October 12, 2025 and sell it today you would earn a total of  94.00  from holding X4 Pharmaceuticals or generate 30.72% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

X4 Pharmaceuticals  vs.  Xilio Development

 Performance 
       Timeline  
X4 Pharmaceuticals 

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in X4 Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain basic indicators, X4 Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.
Xilio Development 

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Xilio Development has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

X4 Pharmaceuticals and Xilio Development Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with X4 Pharmaceuticals and Xilio Development

The main advantage of trading using opposite X4 Pharmaceuticals and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.
The idea behind X4 Pharmaceuticals and Xilio Development pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Commodity Directory
Find actively traded commodities issued by global exchanges